Generex Biotechnology Corporation (OTCMKTS:GNBT) down by 14.51%, Excel Maritime Carriers Ltd (NYSE:EXM)

Posted by Beth Hart May 24, 2013 0 Comment 952 views


Miami, FL 05/24/2013 (GDPInsider) – Generex Biotechnology Corporation (OTCMKTS:GNBT) is trading down by about 14.51% to trade at $0.0330, with a volume of about 10.34 million shares. The introductory price for the stock for the day is $0.04 as compared to its previous close of $0.04. The stock is trading in a range of $0.03 and $0.04 in its current trading session. The stock’s 200 days moving average of $0.044 is currently above the 50 days moving average of $0.029, a sign of pessimism on the stock. The share price is 73.33% below its previous 52-week’s high of $0.12 and 60.00% above its previous 52-week’s low of $0.02. The stock has given a return of 28.67% over a period of 5 days. The performance of the stock has been positive over a period of one month which was 28.67%. The stock has experienced a volatility of 1.36% in the last one month and about 5.71% volatility in the last one week.

How Should Investors Trade GNBT  Now? Get the latest trends and data here.

Excel Maritime Carriers Ltd (NYSE:EXM) is trading down by about 7.16% to trade at $0.520, with a volume of about 0.579 million shares. The introductory price for the stock for the day is $0.52 as compared to its previous close of $0.56. The stock is trading in a range of $0.51 and $0.54 in its current trading session. The stock’s 200 days moving average of $0.55 is currently below the 50 days moving average of $0.66, a sign of optimism on the stock. The share price is 59.40% below its previous 52-week’s high of $1.30 and 46.61% above its previous 52-week’s low of $0.36. The stock has given a return of -5.08% over a period of 5 days. The performance of the stock has been positive over a period of one month which was 24.44%. The stock has experienced a volatility of 12.00% in the last one month and about 16.47% volatility in the last one week.

The company yesterday announced that it received a letter from NYSE on May 16, with regards to non compliance with Rule 802.01E of the NYSE Listed Company Manual since the company failed to file its annual report on Form 20-F for the year ended December 31, 2012.

Is EXM a solid investment at these levels? Get valuable updates and exclusive insights here.

Disclosure:

WallStreetAnalyzed.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetAnalyzed.com website, for complete risks and disclosures.

 


About Beth Hart

Beth is from New York. She has two master’s degrees and served as a lecturer in B-School. Her master’s degree is an MBA in Global Management from the University of Phoenix (2010). She has worked for small businesses, public agencies, and large corporations. She does write articles as a freelancer.

View all post by Beth Hart

Write Your Comment